Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility.
Electrical stimulation therapy
Gastro esophageal reflux disease
Ineffective esophageal motility
Lower esophageal sphincter
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
06
06
2020
accepted:
16
10
2020
pubmed:
1
11
2020
medline:
26
10
2021
entrez:
31
10
2020
Statut:
ppublish
Résumé
Electrical stimulation therapy (EST) of the lower esophageal sphincter (LES) is a novel technique in antireflux surgery. Due to the minimal alteration at the LES during surgery, LES-EST is meant to be ideal for patients with gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM). The aim of this prospective trial (NCT03476265) is to evaluate health-related quality of life and esophageal acid exposure after LES-EST in patients with GERD and IEM. This is a prospective non-randomized open-label study. Patients with GERD and IEM undergoing LES-EST were included. Follow-up (FUP) at 12 months after surgery included health-related quality of life (HRQL) assessment with standardized questionnaires (GERD-HRQL) and esophageal functional testing. According to the study protocol, 17 patients fulfilled eligibility criteria. HRQL score for heartburn and regurgitation improved from 21 (interquartile range (IQR) 15-27) to 7.5 (1.25-19), p = 0.001 and from 17 (11-23.5) to 4 (0-12), p = 0.003, respectively. There was neither significant improvement of esophageal acid exposure nor reduction of number of reflux events in pH impedance measurement. Distal contractile integral improved from 64 (11.5-301) to 115 (IQR 10-363) mmHg s cm, p = 0.249. None of the patients showed any sign of dysphagia after LES-EST. One patient needed re-do surgery and re-implantation of the LES-EST due to breaking of the lead after one year. Although patient satisfaction improved significantly after surgery, this study fails to demonstrate normalization or significant improvement of acid exposure in the distal esophagus after LES-EST.
Sections du résumé
BACKGROUND
Electrical stimulation therapy (EST) of the lower esophageal sphincter (LES) is a novel technique in antireflux surgery. Due to the minimal alteration at the LES during surgery, LES-EST is meant to be ideal for patients with gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM). The aim of this prospective trial (NCT03476265) is to evaluate health-related quality of life and esophageal acid exposure after LES-EST in patients with GERD and IEM.
METHODS
This is a prospective non-randomized open-label study. Patients with GERD and IEM undergoing LES-EST were included. Follow-up (FUP) at 12 months after surgery included health-related quality of life (HRQL) assessment with standardized questionnaires (GERD-HRQL) and esophageal functional testing.
RESULTS
According to the study protocol, 17 patients fulfilled eligibility criteria. HRQL score for heartburn and regurgitation improved from 21 (interquartile range (IQR) 15-27) to 7.5 (1.25-19), p = 0.001 and from 17 (11-23.5) to 4 (0-12), p = 0.003, respectively. There was neither significant improvement of esophageal acid exposure nor reduction of number of reflux events in pH impedance measurement. Distal contractile integral improved from 64 (11.5-301) to 115 (IQR 10-363) mmHg s cm, p = 0.249. None of the patients showed any sign of dysphagia after LES-EST. One patient needed re-do surgery and re-implantation of the LES-EST due to breaking of the lead after one year.
CONCLUSION
Although patient satisfaction improved significantly after surgery, this study fails to demonstrate normalization or significant improvement of acid exposure in the distal esophagus after LES-EST.
Identifiants
pubmed: 33128080
doi: 10.1007/s00464-020-08104-3
pii: 10.1007/s00464-020-08104-3
pmc: PMC8523464
doi:
Banques de données
ClinicalTrials.gov
['NCT03476265']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6101-6107Informations de copyright
© 2020. The Author(s).
Références
Clin Transl Gastroenterol. 2017 Mar 9;8(3):e78
pubmed: 28277491
Surg Endosc. 2002 Jun;16(6):909-13
pubmed: 12163953
J Clin Epidemiol. 1997 Dec;50(12):1311-8
pubmed: 9449934
Surg Endosc. 2019 Nov;33(11):3623-3628
pubmed: 30671665
Gastrointest Endosc. 1984 Dec;30(6):334-9
pubmed: 6210226
Surgery. 2015 Mar;157(3):556-67
pubmed: 25726315
Surg Endosc. 2013 Apr;27(4):1083-92
pubmed: 23073680
BMJ. 1995 Aug 26;311(7004):551-3
pubmed: 7663213
Dis Esophagus. 2020 Apr 15;33(4):
pubmed: 31942976
Surg Endosc. 2018 May;32(5):2365-2372
pubmed: 29234939
Dis Esophagus. 2020 Sep 4;33(9):
pubmed: 32409817
Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1339-46
pubmed: 15637176
Gut. 2019 Nov;68(11):1928-1941
pubmed: 31375601
Surg Endosc. 2007 Jun;21(6):950-4
pubmed: 17177077
World J Surg. 2011 Jan;35(1):78-84
pubmed: 20957361
Neurogastroenterol Motil. 2018 May;30(5):e13276
pubmed: 29266608
Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
Neurogastroenterol Motil. 2019 Sep;31(9):e13584
pubmed: 30974032
Neurogastroenterol Motil. 2016 Feb;28(2):292-8
pubmed: 26575034
J Am Med Assoc. 1955 Dec 24;159(17):1602-6
pubmed: 13271123
BMJ. 2014 May 21;348:g3253
pubmed: 24850821
Neurogastroenterol Motil. 2009 Aug;21(8):796-806
pubmed: 19413684
BMC Med Res Methodol. 2005 Aug 18;5:26
pubmed: 16109176
J Gastrointest Surg. 1998 Mar-Apr;2(2):141-5
pubmed: 9834409
Neurogastroenterol Motil. 2012 May;24(5):446-50, e213
pubmed: 22292889
Scand J Gastroenterol Suppl. 1984;92:237-41
pubmed: 6588522